Profile of depression in adolescents with inflammatory bowel disease: Implications for treatment
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The purpose was to determine the utility of including neurovegetative symptoms in assessments of depression in youth with inflammatory bowel disease (IBD). METHODS: Forty-one youth with IBD and concurrent depressive symptomatology were enrolled in an intervention trial and received either 9 modules of cognitive-behavioral therapy (PASCET-PI) or treatment as usual (TAU). Youth and their primary caregivers completed the Children's Depression Inventory (CDI) at pre- (T1) and posttreatment (T2). Disease severity measures and current steroid dosage were obtained at each timepoint. Change in the individual items of the CDI was compared across groups and examined in association with change in physical illness course. RESULTS: Paired sample t-tests revealed significant changes in CDI item scores from T1 to T2 for a majority of the depressive symptoms assessed in the PASCET-PI group, but not for the TAU group. These changes did not appear to be linked to changes in disease severity and/or steroid dosage across these same timepoints. CONCLUSIONS: The inclusion of somatic items in the assessment of depression in physically ill youth is important, as these symptoms seem to respond to psychotherapeutic intervention. The present results would suggest that improvements in depressive symptomatology are not solely related to improvements in the course of IBD and that these items do reflect an important part of the profile of depressive symptoms in youth with IBD. Future research is warranted to replicate present findings and explore the generalizability of these results to other pediatric illness populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120
SZIGETHY, E., KENNEY, E., CARPENTER, J., HARDY, D. M., FAIRCLOUGH, D., BOUSVAROS, A., KELJO, D., WEISZ, J., BEARDSLEE, W. R., NOLL, R., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180f6341f · Cited by 183
Self-citationHart, S., Fonareva, I., Merluzzi, N., & Mohr, D. C. (2005) · Quality of Life Research · doi:10.1007/s11136-004-1364-z · Cited by 128
SZIGETHY, E., WHITTON, S. W., LEVY-WARREN, A., DeMaso, D. R., WEISZ, J., & BEARDSLEE, W. R. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000142284.10574.1f · Cited by 92
Cited by
Psychological interventions for treatment of inflammatory bowel disease
Timmer, A., Preiss, J. C., Motschall, E., Rücker, G., Jantschek, G., & Moser, G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006913.pub2 · Cited by 187
Etiology and Treatment of Pain and Psychosocial Issues in Patients With Inflammatory Bowel Diseases
Regueiro, M., Greer, J. B., & Szigethy, E. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.036 · Cited by 142
Increased Risks of Developing Anxiety and Depression in Young Patients With Crohn's Disease
Loftus, E. V., Guérin, A., Yu, A. P., Wu, E. Q., Yang, M., Chao, J., & Mulani, P. M. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.142 · Cited by 142
Pain management in patients with inflammatory bowel disease: insights for the clinician
Srinath, A. I., Walter, C., Newara, M. C., & Szigethy, E. M. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12446158 · Cited by 111
Self-citationSzigethy, E. M., Allen, J. I., Reiss, M., Cohen, W., Perera, L. P., Brillstein, L., Cross, R. K., Schwartz, D. A., Kosinski, L. R., Colton, J. B., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.02.037 · Cited by 107
Self-citationDepression subtypes in pediatric inflammatory bowel disease
Szigethy, E. M., Youk, A. O., Benhayon, D., Fairclough, D. L., Newara, M. C., Kirshner, M. A., Bujoreanu, S. I., Mrakotsky, C., Bousvaros, A., Srinath, A. I., et al. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000262 · Cited by 65
Self-citationThe Overlap of Functional Abdominal Pain in Pediatric Crohn’s Disease
Zimmerman, L. A., Srinath, A. I., Goyal, A., Bousvaros, A., Ducharme, P., Szigethy, E., & Nurko, S. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182802a0a · Cited by 65
“Previous studies have shown that anxiety and depression are prevalent in children with IBD.14,15 This psychological distress can influence coping ability, pain perception, and disease activity.16 A recent study in adult patients with CD has demonstrated higher levels of depression compared with healthy controls, espec…”
BackgroundInfluentialSelf-citationvan den Brink, G., Stapersma, L., Vlug, L. E., Rizopolous, D., Bodelier, A. G., van Wering, H., Hurkmans, P. C. W. M., Stuyt, R. J. L., Hendriks, D. M., van der Burg, J. A. T., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14832 · Cited by 61
Pediatric inflammatory bowel disease and depression: treatment implications
Keethy, D., Mrakotsky, C., & Szigethy, E. (2014) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000129 · Cited by 40
“In children and adolescents with IBD, treating subsyndromal depressive symptoms with cognitive behavioral therapy (CBT) correlated with significantly greater improvement of overall depressive severity, as well as somatic symptoms compared with medical treatment as usual [53,54].”
BackgroundSelf-citationReigada, L. C., Benkov, K. J., Bruzzese, J., Hoogendoorn, C., Szigethy, E., Briggie, A., Walder, D. J., & Warner, C. M. (2013) · Journal for Specialists in Pediatric Nursing · doi:10.1111/jspn.12019 · Cited by 34
“Initial findings of a controlled trial (N = 41) demonstrated that CBT can reduce somatic symptoms and may buffer patients from depressive symptom relapse during later disease exacerbations (Szigethy et al., 2009).”
BackgroundSelf-citationThompson, R. D., Craig, A. E., Mrakotsky, C., Bousvaros, A., DeMaso, D. R., & Szigethy, E. (2012) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2012.04.006 · Cited by 26
Self-citation
Metadata
- Authors
- Szigethy, E., Craig, A. E., Iobst, E. A., Grand, R. J., Keljo, D., DeMaso, D., & Noll, R.
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-01
- Volume
- 15
- Issue
- 1
- Pages
- 69-74
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W1978009979
- Cited by
- 43
- References
- 4
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.